October 3 - 5, 2021
November 18 - 19, 2021
The workshop will be held in English.
The workshop will be live streamed in a Zoom Webinar format. The session times are CET (Central European Time).
Prof. Filipe Caseiro Alves
University of Coimbra
Coimbra, Portugal
Dr. Manuela França
Centro Hospitalar Universitário do Porto
Porto, Portugal
H. Alexandrino, Coimbra/PT
A. Ba-Ssalamah, Vienna/AT
T. Bilhim, Lisbon/PT
F. Caseiro Alves, Coimbra/PT
A. Denys/CH
R. Duran, Lausanne/CH
M. França, Porto/PT
L. Martí-Bonmatí, Valencia/ES
C. Matos, Lisbon/PT
Y. Menu, Paris/FR
R. Oliveira, Coimbra/PT
M. Ronot, Clichy/FR
I. Santiago, Lisbon/PT
| Primary liver tumors - I Moderators: F. Caseiro-Alves, M. França/PT | ||
| 09:00 | Welcome and introduction | F. Caseiro Alves & M. França/PT |
| 09:05 | Update on recent published data about HCC: radiologist | L. Martí-Bonmatí/ES |
| 09:20 | HCC phenotypes, molecular signatures and clinical implications: pathology | R. Oliveira/PT |
| 09:35 | HCC phenotypes, molecular signatures and clinical implications: surgery | H. Alexandrino/PT |
| 09:50 | Case-based review: HCC | F. Caseiro Alves/PT |
| 10:20 | HCC in non-cirrhotic liver (cases 15' / lecture 10') | M. França/PT |
| 10:45 | Q&A | |
| 11:15 | Break | |
| Primary liver tumors - II Moderator: T. Bilhim/PT | ||
12:00 | IR and HCC treatment (cases 20' / lecture 10') | R. Duran/CH |
| 12:30 | HCC after locoregional treatments (cases 20' / lecture 10’) | M. Ronot/FR |
| 13:00 | Immunotherapy in liver cancer: tumour response assessment (cases: 10' / lecture: 20') | Y. Menu/FR |
| 13:30 | Q&A | |
| 14:00 | Break | |
| Primary liver tumors - III Moderator: L. Marti-Bonmati/ES | ||
| 15:00 | MDT: HCC Panellists: H. Alexandrino/PT, M. Ronot/FR, R. Duran/CH | L. Martí-Bonmatí/ES |
| 16:00 | Diagnosis of cholangiocarcinoma (cases: 20' / lecture: 10') | C. Matos/PT |
| 16:30 | Update on recent published data about cholangiocarcinoma | M. Ronot/FR |
| 16:45 | Q&A | |
| 17:15 | Break | |
| Primary liver tumors - IV Moderator: M. Ronot/FR | ||
| 18:00 | Treatment of cholangiocarcinoma: surgical | H. Alexandrino/PT |
| 18:30 | Treatment of cholangiocarcinoma: interventional radiology | R. Duran/CH |
| 19:00 | MDT: cholangiocarcinoma Panellists: C. Matos/PT, R. Duran/CH, H. Alexandrino/PT | M. Ronot/FR |
| 20:00 | Adjourn | |
| ||
| Colorectalliver metastases: diagnosis - V Moderator: A. Ba-Ssalamah/AT | ||
| 09:00 | State-of-the-art diagnosis: radiology | I. Santiago/PT |
| 09:20 | State-of-the-art diagnosis: pathology | R. Oliveira/PT |
| 09:40 | Update on recent published data | Y. Menu/FR |
| 09:55 | Case-based learning | A. Ba-Ssalamah/AT |
| 10:35 | Q&A | |
| 11:00 | Break | |
| Colorectalliver metastases: treatment - VI Moderator: Y. Menu/FR | ||
| 11:45 | Treatment CRC metastases: how I do it - interventional radiology | T. Bilhim/PT |
| 12:15 | Surgical options and new frontiers | H. Alexandrino/PT |
| 12:45 | MDT: liver metastases Panellists: T. Bilhim/PT, F. Caseiro-Alves/PT, H. Alexandrino/PT | Y. Menu/FR |
| 13:45 | Q&A | |
| 14.15 | Break | |
| Other metastases and rare liver tumours - VII Moderator: M. França/PT | ||
| 15:15 | Update on recent published data about non-colorectal liver metastasis | I. Santiago/PT |
| 15:30 | Diagnosis of non-colorectal liver metastasis | M. Ronot/FR |
| 16:00 | Diagnosis and treatment of non-colorectal liver metastasis: interventional radiology | A. Denys/CH |
| 16:30 | Other (rare) malignant liver neoplasms | M. França/PT |
| 17:00 | Q&A | |
| 17:30 | Break | |
| 18:15 | MDT: difficult cases of liver tumours M. Ronot/FR, T. Bilhim/PT, H. Alexandrino/PT | I. Santiago/PT |
| 19:15 | Adjourn | |
| Radiologists | |
ESGAR Member | € 330.00 |
Non Member | € 540.00 |
| Radiologists in Training (Residents) | |
| ESGAR Member | € 120.00 |
| Non Member | € 220.00 |
The number of participants per workshop is limited and registrations will be accepted on a first come first served basis. Together with the registration payment is necessary. Registrations as radiologist in training (Residents) or Radiographers must be accompanied by a confirmation of the head of the department confirming the status as Resident or Radiographer.
CME European credits:
“The ESGAR Case-based Workshop in Liver Oncology, Vienna (ONLINE), Austria, 18/11/2021-19/11/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 15 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”
“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”
How to obtain your CME certificate:
CME certificates will be provided to participants participating in the live workshop sessions AND completing the respective evaluation form. The number of hours will be calculated according to the actual time spent participating in the live sessions.